 | • レポートコード：GIR-23F3815 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Heart Failure Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の心不全治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 心不全治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・ACEI、アンジオテンシンII受容体拮抗薬、ARNI、β遮断薬、アルドステロン拮抗薬、利尿薬 アプリケーション別セグメントは次のように区分されます。 ・駆出率低減、駆出率維持 世界の心不全治療薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・Novartis、Pfizer、AstraZeneca、Hikma、Teva、Cipla、Merck & Co.、Amgen、Roche、Sun Pharma、Mylan 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 心不全治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：ACEI、アンジオテンシンII受容体拮抗薬、ARNI、β遮断薬、アルドステロン拮抗薬、利尿薬 - アプリケーション別分析（2017年vs2021年vs2028年）：駆出率低減、駆出率維持 - 世界の心不全治療薬市場規模・予測 - 世界の心不全治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Novartis、Pfizer、AstraZeneca、Hikma、Teva、Cipla、Merck & Co.、Amgen、Roche、Sun Pharma、Mylan ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：ACEI、アンジオテンシンII受容体拮抗薬、ARNI、β遮断薬、アルドステロン拮抗薬、利尿薬 ・アプリケーション別分析2017年-2028年：駆出率低減、駆出率維持 ・心不全治療薬の北米市場分析 - 心不全治療薬の北米市場：タイプ別市場規模2017年-2028年 - 心不全治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・心不全治療薬のヨーロッパ市場分析 - ：心不全治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：心不全治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・心不全治療薬のアジア太平洋市場分析 - 心不全治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 心不全治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・心不全治療薬の南米市場分析 - 心不全治療薬の南米市場：タイプ別市場規模2017年-2028年 - 心不全治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・心不全治療薬の中東・アフリカ市場分析 - 心不全治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 心不全治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Heart Failure Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Heart Failure Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Reduced Ejection Fraction accounting for % of the Heart Failure Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While ACEI segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Heart Failure Drugs include Novartis, Pfizer, AstraZeneca, Hikma, and Teva, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Heart Failure Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Market segment by Application can be divided into
Reduced Ejection Fraction
Preserved Ejection Fraction
The key market players for global Heart Failure Drugs market are listed below:
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heart Failure Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Heart Failure Drugs, with price, sales, revenue and global market share of Heart Failure Drugs from 2019 to 2022.
Chapter 3, the Heart Failure Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heart Failure Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Heart Failure Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Heart Failure Drugs.
Chapter 13, 14, and 15, to describe Heart Failure Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Heart Failure Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Heart Failure Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Market Analysis by Application
1.3.1 Overview: Global Heart Failure Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Global Heart Failure Drugs Market Size & Forecast
1.4.1 Global Heart Failure Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Heart Failure Drugs Sales in Volume (2017-2028)
1.4.3 Global Heart Failure Drugs Price (2017-2028)
1.5 Global Heart Failure Drugs Production Capacity Analysis
1.5.1 Global Heart Failure Drugs Total Production Capacity (2017-2028)
1.5.2 Global Heart Failure Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Heart Failure Drugs Market Drivers
1.6.2 Heart Failure Drugs Market Restraints
1.6.3 Heart Failure Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Heart Failure Drugs Product and Services
2.1.4 Novartis Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Heart Failure Drugs Product and Services
2.2.4 Pfizer Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Heart Failure Drugs Product and Services
2.3.4 AstraZeneca Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Hikma
2.4.1 Hikma Details
2.4.2 Hikma Major Business
2.4.3 Hikma Heart Failure Drugs Product and Services
2.4.4 Hikma Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business
2.5.3 Teva Heart Failure Drugs Product and Services
2.5.4 Teva Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Heart Failure Drugs Product and Services
2.6.4 Cipla Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck & Co.
2.7.1 Merck & Co. Details
2.7.2 Merck & Co. Major Business
2.7.3 Merck & Co. Heart Failure Drugs Product and Services
2.7.4 Merck & Co. Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Heart Failure Drugs Product and Services
2.8.4 Amgen Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Heart Failure Drugs Product and Services
2.9.4 Roche Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Sun Pharma
2.10.1 Sun Pharma Details
2.10.2 Sun Pharma Major Business
2.10.3 Sun Pharma Heart Failure Drugs Product and Services
2.10.4 Sun Pharma Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business
2.11.3 Mylan Heart Failure Drugs Product and Services
2.11.4 Mylan Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Heart Failure Drugs Breakdown Data by Manufacturer
3.1 Global Heart Failure Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Heart Failure Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Heart Failure Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Heart Failure Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Heart Failure Drugs Manufacturer Market Share in 2021
3.5 Global Heart Failure Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Heart Failure Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Heart Failure Drugs Market Size by Region
4.1.1 Global Heart Failure Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Heart Failure Drugs Revenue by Region (2017-2028)
4.2 North America Heart Failure Drugs Revenue (2017-2028)
4.3 Europe Heart Failure Drugs Revenue (2017-2028)
4.4 Asia-Pacific Heart Failure Drugs Revenue (2017-2028)
4.5 South America Heart Failure Drugs Revenue (2017-2028)
4.6 Middle East and Africa Heart Failure Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Heart Failure Drugs Sales in Volume by Type (2017-2028)
5.2 Global Heart Failure Drugs Revenue by Type (2017-2028)
5.3 Global Heart Failure Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Heart Failure Drugs Sales in Volume by Application (2017-2028)
6.2 Global Heart Failure Drugs Revenue by Application (2017-2028)
6.3 Global Heart Failure Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Heart Failure Drugs Sales by Type (2017-2028)
7.2 North America Heart Failure Drugs Sales by Application (2017-2028)
7.3 North America Heart Failure Drugs Market Size by Country
7.3.1 North America Heart Failure Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Heart Failure Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Heart Failure Drugs Sales by Type (2017-2028)
8.2 Europe Heart Failure Drugs Sales by Application (2017-2028)
8.3 Europe Heart Failure Drugs Market Size by Country
8.3.1 Europe Heart Failure Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Heart Failure Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Heart Failure Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Heart Failure Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Heart Failure Drugs Market Size by Region
9.3.1 Asia-Pacific Heart Failure Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Heart Failure Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Heart Failure Drugs Sales by Type (2017-2028)
10.2 South America Heart Failure Drugs Sales by Application (2017-2028)
10.3 South America Heart Failure Drugs Market Size by Country
10.3.1 South America Heart Failure Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Heart Failure Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Heart Failure Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Heart Failure Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Heart Failure Drugs Market Size by Country
11.3.1 Middle East & Africa Heart Failure Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Heart Failure Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Heart Failure Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Heart Failure Drugs
12.3 Heart Failure Drugs Production Process
12.4 Heart Failure Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Heart Failure Drugs Typical Distributors
13.3 Heart Failure Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Heart Failure Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Heart Failure Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Heart Failure Drugs Product and Services
Table 6. Novartis Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Heart Failure Drugs Product and Services
Table 10. Pfizer Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Heart Failure Drugs Product and Services
Table 14. AstraZeneca Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Hikma Basic Information, Manufacturing Base and Competitors
Table 16. Hikma Major Business
Table 17. Hikma Heart Failure Drugs Product and Services
Table 18. Hikma Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Teva Basic Information, Manufacturing Base and Competitors
Table 20. Teva Major Business
Table 21. Teva Heart Failure Drugs Product and Services
Table 22. Teva Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Cipla Basic Information, Manufacturing Base and Competitors
Table 24. Cipla Major Business
Table 25. Cipla Heart Failure Drugs Product and Services
Table 26. Cipla Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 28. Merck & Co. Major Business
Table 29. Merck & Co. Heart Failure Drugs Product and Services
Table 30. Merck & Co. Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Amgen Basic Information, Manufacturing Base and Competitors
Table 32. Amgen Major Business
Table 33. Amgen Heart Failure Drugs Product and Services
Table 34. Amgen Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Roche Basic Information, Manufacturing Base and Competitors
Table 36. Roche Major Business
Table 37. Roche Heart Failure Drugs Product and Services
Table 38. Roche Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Sun Pharma Major Business
Table 41. Sun Pharma Heart Failure Drugs Product and Services
Table 42. Sun Pharma Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Major Business
Table 45. Mylan Heart Failure Drugs Product and Services
Table 46. Mylan Heart Failure Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Heart Failure Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 48. Global Heart Failure Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Heart Failure Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Heart Failure Drugs Production Capacity by Company, (MT): 2020 VS 2021
Table 51. Head Office and Heart Failure Drugs Production Site of Key Manufacturer
Table 52. Heart Failure Drugs New Entrant and Capacity Expansion Plans
Table 53. Heart Failure Drugs Mergers & Acquisitions in the Past Five Years
Table 54. Global Heart Failure Drugs Sales by Region (2017-2022) & (MT)
Table 55. Global Heart Failure Drugs Sales by Region (2023-2028) & (MT)
Table 56. Global Heart Failure Drugs Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Heart Failure Drugs Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 59. Global Heart Failure Drugs Sales by Type (2023-2028) & (MT)
Table 60. Global Heart Failure Drugs Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Heart Failure Drugs Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Heart Failure Drugs Price by Type (2017-2022) & (USD/MT)
Table 63. Global Heart Failure Drugs Price by Type (2023-2028) & (USD/MT)
Table 64. Global Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 65. Global Heart Failure Drugs Sales by Application (2023-2028) & (MT)
Table 66. Global Heart Failure Drugs Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Heart Failure Drugs Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Heart Failure Drugs Price by Application (2017-2022) & (USD/MT)
Table 69. Global Heart Failure Drugs Price by Application (2023-2028) & (USD/MT)
Table 70. North America Heart Failure Drugs Sales by Country (2017-2022) & (MT)
Table 71. North America Heart Failure Drugs Sales by Country (2023-2028) & (MT)
Table 72. North America Heart Failure Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Heart Failure Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 75. North America Heart Failure Drugs Sales by Type (2023-2028) & (MT)
Table 76. North America Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 77. North America Heart Failure Drugs Sales by Application (2023-2028) & (MT)
Table 78. Europe Heart Failure Drugs Sales by Country (2017-2022) & (MT)
Table 79. Europe Heart Failure Drugs Sales by Country (2023-2028) & (MT)
Table 80. Europe Heart Failure Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Heart Failure Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 83. Europe Heart Failure Drugs Sales by Type (2023-2028) & (MT)
Table 84. Europe Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 85. Europe Heart Failure Drugs Sales by Application (2023-2028) & (MT)
Table 86. Asia-Pacific Heart Failure Drugs Sales by Region (2017-2022) & (MT)
Table 87. Asia-Pacific Heart Failure Drugs Sales by Region (2023-2028) & (MT)
Table 88. Asia-Pacific Heart Failure Drugs Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Heart Failure Drugs Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 91. Asia-Pacific Heart Failure Drugs Sales by Type (2023-2028) & (MT)
Table 92. Asia-Pacific Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 93. Asia-Pacific Heart Failure Drugs Sales by Application (2023-2028) & (MT)
Table 94. South America Heart Failure Drugs Sales by Country (2017-2022) & (MT)
Table 95. South America Heart Failure Drugs Sales by Country (2023-2028) & (MT)
Table 96. South America Heart Failure Drugs Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Heart Failure Drugs Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 99. South America Heart Failure Drugs Sales by Type (2023-2028) & (MT)
Table 100. South America Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 101. South America Heart Failure Drugs Sales by Application (2023-2028) & (MT)
Table 102. Middle East & Africa Heart Failure Drugs Sales by Region (2017-2022) & (MT)
Table 103. Middle East & Africa Heart Failure Drugs Sales by Region (2023-2028) & (MT)
Table 104. Middle East & Africa Heart Failure Drugs Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Heart Failure Drugs Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 107. Middle East & Africa Heart Failure Drugs Sales by Type (2023-2028) & (MT)
Table 108. Middle East & Africa Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 109. Middle East & Africa Heart Failure Drugs Sales by Application (2023-2028) & (MT)
Table 110. Heart Failure Drugs Raw Material
Table 111. Key Manufacturers of Heart Failure Drugs Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Heart Failure Drugs Typical Distributors
Table 115. Heart Failure Drugs Typical Customers
List of Figures
Figure 1. Heart Failure Drugs Picture
Figure 2. Global Heart Failure Drugs Revenue Market Share by Type in 2021
Figure 3. ACEI
Figure 4. Angiotensin II Receptor Blockers
Figure 5. ARNIs
Figure 6. Beta Blockers
Figure 7. Aldosterone Antagonists
Figure 8. Diuretics
Figure 9. Global Heart Failure Drugs Revenue Market Share by Application in 2021
Figure 10. Reduced Ejection Fraction
Figure 11. Preserved Ejection Fraction
Figure 12. Global Heart Failure Drugs Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 13. Global Heart Failure Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Heart Failure Drugs Sales (2017-2028) & (MT)
Figure 15. Global Heart Failure Drugs Price (2017-2028) & (USD/MT)
Figure 16. Global Heart Failure Drugs Production Capacity (2017-2028) & (MT)
Figure 17. Global Heart Failure Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Heart Failure Drugs Market Drivers
Figure 19. Heart Failure Drugs Market Restraints
Figure 20. Heart Failure Drugs Market Trends
Figure 21. Global Heart Failure Drugs Sales Market Share by Manufacturer in 2021
Figure 22. Global Heart Failure Drugs Revenue Market Share by Manufacturer in 2021
Figure 23. Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Heart Failure Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Heart Failure Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Heart Failure Drugs Sales Market Share by Region (2017-2028)
Figure 27. Global Heart Failure Drugs Revenue Market Share by Region (2017-2028)
Figure 28. North America Heart Failure Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Europe Heart Failure Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Heart Failure Drugs Revenue (2017-2028) & (USD Million)
Figure 31. South America Heart Failure Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Heart Failure Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Global Heart Failure Drugs Sales Market Share by Type (2017-2028)
Figure 34. Global Heart Failure Drugs Revenue Market Share by Type (2017-2028)
Figure 35. Global Heart Failure Drugs Price by Type (2017-2028) & (USD/MT)
Figure 36. Global Heart Failure Drugs Sales Market Share by Application (2017-2028)
Figure 37. Global Heart Failure Drugs Revenue Market Share by Application (2017-2028)
Figure 38. Global Heart Failure Drugs Price by Application (2017-2028) & (USD/MT)
Figure 39. North America Heart Failure Drugs Sales Market Share by Type (2017-2028)
Figure 40. North America Heart Failure Drugs Sales Market Share by Application (2017-2028)
Figure 41. North America Heart Failure Drugs Sales Market Share by Country (2017-2028)
Figure 42. North America Heart Failure Drugs Revenue Market Share by Country (2017-2028)
Figure 43. United States Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Heart Failure Drugs Sales Market Share by Type (2017-2028)
Figure 47. Europe Heart Failure Drugs Sales Market Share by Application (2017-2028)
Figure 48. Europe Heart Failure Drugs Sales Market Share by Country (2017-2028)
Figure 49. Europe Heart Failure Drugs Revenue Market Share by Country (2017-2028)
Figure 50. Germany Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Heart Failure Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Heart Failure Drugs Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Heart Failure Drugs Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Heart Failure Drugs Revenue Market Share by Region (2017-2028)
Figure 59. China Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Heart Failure Drugs Sales Market Share by Type (2017-2028)
Figure 66. South America Heart Failure Drugs Sales Market Share by Application (2017-2028)
Figure 67. South America Heart Failure Drugs Sales Market Share by Country (2017-2028)
Figure 68. South America Heart Failure Drugs Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Heart Failure Drugs Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Heart Failure Drugs Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Heart Failure Drugs Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Heart Failure Drugs Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Heart Failure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Heart Failure Drugs in 2021
Figure 80. Manufacturing Process Analysis of Heart Failure Drugs
Figure 81. Heart Failure Drugs Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source